• Driving bacteria to produce potential an

    From ScienceDaily@1337:3/111 to All on Thu Jun 25 21:30:24 2020
    Driving bacteria to produce potential antibiotic, antiparasitic
    compounds

    Date:
    June 25, 2020
    Source:
    University of Illinois at Urbana-Champaign, News Bureau
    Summary:
    Researchers have developed a method to spur the production of new
    antibiotic or antiparasitic compounds hiding in the genomes of
    actinobacteria, which are the source of the drugs actinomycin and
    streptomycin and are known to harbor other untapped chemical riches.



    FULL STORY ========================================================================== [Bacteria illustration | Credit: (c) Paulista / stock.adobe.com] Bacteria illustration (stock image).

    Credit: (c) Paulista / stock.adobe.com [Bacteria illustration | Credit:
    (c) Paulista / stock.adobe.com] Bacteria illustration (stock image).

    Credit: (c) Paulista / stock.adobe.com Close Researchers have developed
    a method to spur the production of new antibiotic or antiparasitic
    compounds hiding in the genomes of actinobacteria, which are the source
    of drugs such as actinomycin and streptomycin and are known to harbor
    other untapped chemical riches. The scientists report their findings in
    the journal eLife.


    ==========================================================================
    The researchers wanted to overcome a decades-old problem that confronts
    those hoping to study and make use of the countless antibiotic, antifungal
    and antiparasitic compounds that bacteria can produce, said Satish Nair,
    a University of Illinois at Urbana-Champaign professor of biochemistry
    who led the research.

    "In laboratory conditions, bacteria don't make the number of molecules
    they have the capability of making," he said. "And that's because many
    are regulated by small-molecule hormones that aren't produced unless
    the bacteria are under threat." Nair and his colleagues wanted to
    determine how such hormones influence the production of antibiotics
    in actinobacteria. By exposing their bacteria to the right hormone or combination of hormones, the researchers hope to spur the microbes to
    produce new compounds that are medically useful.

    The team focused on avenolide, a hormone that is more chemically
    stable than one used in earlier studies of bacterial hormones. Avenolide regulates the production of an antiparasitic compound known as avermectin
    in a soil microbe.

    A chemically modified version of this compound, ivermectin, is used as
    a treatment for river blindness, a disease transmitted by flies that
    blinded millions of people, mostly in sub-Saharan Africa, before the
    drug was developed.

    For the new study, chemistry graduate student Iti Kapoor developed a
    more streamlined process for synthesizing avenolide in the lab than
    was previously available. This allowed the team to study the hormone's interactions with its receptor both inside and outside bacterial cells.

    "Using a method called X-ray crystallography, Iti and biochemistry
    graduate student Philip Olivares were able to determine how the hormone
    binds to its receptor and how the receptor binds to the DNA in the absence
    of hormones," Nair said. "Typically, these receptors sit on the genome
    and they basically act as brakes." The researchers discovered that
    when the hormone binds to it, the receptor loses its ability to cling
    to DNA. This turns off the brakes, allowing the organism to churn out
    defensive compounds like antibiotics.

    Knowing which regions of the receptor are involved in binding to the
    hormone and to the DNA enabled the team to scan the genomes of dozens
    of actinobacteria to find sequences that had the right traits to bind
    to their receptor or to similar receptors. This process, called genome
    mining, allowed the team to identify 90 actinobacteria that appear to
    be regulated by avenolide or other hormones in the same class.

    "Our long-term project is to take those 90 bacteria, grow them up in
    the laboratory, add chemically synthesized hormones to them and see
    what new molecules are being produced," Nair said. "The beauty of our
    approach is that we can now get the bacteria to produce large quantities
    of molecules that normally we would not be able to make in the lab."
    Some of these new compounds are likely to have medical relevance, he said.


    ========================================================================== Story Source: Materials provided by University_of_Illinois_at_Urbana-Champaign,_News_Bureau.

    Original written by Diana Yates. Note: Content may be edited for style
    and length.


    ========================================================================== Journal Reference:
    1. Iti Kapoor, Philip Olivares, Satish K Nair. Biochemical basis
    for the
    regulation of biosynthesis of antiparasitics by bacterial hormones.

    eLife, 2020; 9 DOI: 10.7554/eLife.57824 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/06/200625122735.htm

    --- up 22 weeks, 2 days, 2 hours, 34 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)